
ignore medications just because the
treatment is worse than the disease how
many of us have taken
anti-inflammatories to come to the
realization that the side effects are as
warz as the disease symptoms
breakthroughs in precision medicine and
health going on at Virginia Tech are
about to change this trend Virginia Tech
has a unique opportunity to profoundly
change the drug development landscape in
the US and globally let the food be thy
medicine and medicine be thy food hi
pocket is the father of modern medicine
who is portrayed as the Paragon as the
ancient Greek physician had a clear
understanding of the connections between
food and medicine the medicinal value of
foods this concept is at the very core
of nutritional immunology research that
Virginia Tech is pioneering yet this
ancient principle of utilizing
nutritional foods as medicine is only
benefiting right now about 8% of the
u.s. population only about 8% of us are
for instance taking the five to nine
servings of fruits and vegetables that
are recommended the remaining ninety two
bio complexity this picture is at the
very core of bio complexity it
illustrates the interactions between
diet and foods where we have hundreds
maybe thousands of choices every day
trillions of bacteria in our intestines
and complex biochemical pathways that
drive
use of those nutrients in our intestines
which are intimately connected with an
immune system that can choose to be
when these systems get out of sync when
there’s a dysregulation at any of these
levels then disease follows and the God
the dysregulated God the God that is out
of balance has us running to the
hospital
I’ll talk now about Assad but a very
real example of stool Walker stew Walker
is a young man from West Yorkshire
England he wants to be normal he seems
healthy
however stew is not normal a store
requires feeding through a cube in his
nose a stool has a colostomy bag
connected to his abdomen and to his god
a store is one of four million people of
individuals worldwide afflicted by
inflammatory bowel disease an autoimmune
disease without a cure and with two
clinical manifestations Crohn’s disease
and ulcerative colitis current
treatments for IBD are modestly
successful in some cases 30 to 40
percent of patients benefit from those
treatments the side effects are severe
ranging from infection to cancer to
the cost of these medications is about
$50,000 per patient per year yes you
heard it right fifty thousand dollars
per patient per year and about seventy
percent of those patients will require
surgery in some cases several surgeries
in fact Stu has undergone several
surgeries to deal with his IBD this is a
symptom of a broader problem which is
illustrated by what we call the sideways
funnel of the drug development process
in the US there’s an inefficiency that
is embedded in the drug development
process from Discovery to preclinical
testing in animals to face one to three
clinical testing the process is
inefficient and slow-moving let’s look
at some facts and figures some food for
thought about developing a drug costs
about 1.2 billion dollars the timeline
for developing a drug for Crohn’s
disease is about 10 to 15 years and only
one in over 10,000 molecules are going
to make it there’s a cost efficiency
problem there’s an inefficiency problem
and you might ask what is our aim our
aim is to fold first to find a solution
for the needs of Stuart and the other 4
million people globally we need to find
safer and more effective medications for
IBD but second and equally importantly
to help address the inefficiency of the
drug development process let’s think
about it how can we accomplish that
engineers have over the years been using
effectively modeling and simulation the
power of high performance computing to
minimize
an error in building airplanes rocket
launchers even atomic bombs
the use of computational modeling
mechanistic modeling agent based
modeling in medicine is just beginning
to scratch the surface we believe that
there’s an opportunity in becoming the
engineers of the gut biochemical
biomedical researchers can become the
engineers of the guard the engineers of
the immune system we’ve come a long way
since hypotheses established his opinion
on the value of food as a medicinal
concept we’ve celebrated metchnikoff
as the discoverer of the macrophages one
of the immune cells monoclonal
antibodies have paved the way for
targeted research on a specific pathways
sequencing has improved performance up
to 10,000 fold over the last four to
five years and cost of sequencing have
steadily gone down computational
technologies have the potential to drive
the nave next revolution in biomedicine
research and in drug discovery we talked
about bio complexity the intestine is a
complex system one that we must
understand if we have to find people who
are able to find a cure for IBD we have
40 trillion bacteria 30 trillion cells
pro-inflammatory anti-inflammatory they
can be pro-inflammatory depending on the
environment or anti-inflammatory and
there’s plasticity that switches from a
pro to anti-inflammatory State believe
it or not 70 to 75 percent of the immune
system is present in our gut and the
surface area of our God is about the
size of two tennis courts
there’s trillions of interactions and we
must understand the God and the immune
system completely and in its entirety to
be able to make measure advances in the
development of cures for IBD the spark
here is the application of modeling and
simulation technologies the application
of the power of high-performance
computing to build models that will help
Stu and the other four million people
afflicted by IBD Virginia Tech is
leading the way on building
computational models of the stomach
during h pylori infection of the lower
intestine
during australium difficile infection
and yes we are also building models of
inflammatory bowel disease not only to
understand the basic fundamental
mechanisms that drive the immune system
to become dysregulated and destroy the
intestine but more importantly to
identify new cures for inflammatory
bowel disease even the youngest members
of this audience know how to solve the
equation of two plus two equals four not
all of us can solve the equation listed
in this slide well what this is telling
us that in order to make a meaningful
impact on drug discovery and on the
understanding of god immunology we need
to establish teams of mathematicians
computer scientists immunologist
formulation experts clinicians and
translational researchers and this
research is going on here
at Virginia Tech this is a clear example
of a destination for the University we
have utilized these modeling
technologies some of them similar to
what Google is utilizing on its engine
in its searches others that are ordinary
differential equations or agent-based
modeling to go from experimental
data to dissecting the whole organism
the tissue the cells and the molecules
and these analyses allow us to identify
new therapeutic targets one such example
of those promising therapeutic targets
is lanthanum synthetase you like to
discover here at Virginia Tech and a
promising Avenue to find a cure for
inflammatory bowel disease
Alan cl2 intercepts inflammatory bowel
disease at two levels first it
suppresses the pro inflammatory
mediators linked to IBD and next it
amplifies the anti inflammatory response
this technology is gaining momentum and
has been validated by the National
Institutes of Health the American
gastroenterology Association and the
Crohn’s and Colitis foundation of
America you don’t need to be a
board-certified pathologist to
understand that there’s a difference
between these two pictures on your left
we have an intestine from a mouse with
IBD the wall is thicker the architecture
is deranged there’s infiltration of
inflammatory cells on the right we have
an intestine of a mouse with IBD that
has been treated with a new drug that
targets lanthanum synthetase like to the
new drug is called BT 11 and what that
drug does is make those things on the of
the intestine be thinner less
inflammatory cell infiltration and
maintenance of the architecture we can
take modeling one step further we can
design the next generation of human
clinical trials we are using clinical
information from electronic health
records biological data demographic
information immunological datasets
to build avatars populations of patients
with inflammatory bowel disease
specifically Crohn’s disease where we
can test not only existing drugs but new
drugs I just beat the 11 and we have
accomplished that here those are the
results of comparing our new drug bt 11
which in mouse study showed efficacy at
8 milligrams per kilo and safety in
doses as high as 1000 milligrams per
kilo tested in human avatars and what
this data shows is that bt 11
outperforms current standard of care as
well as drugs in development we’ve come
a long way from hypothesis let food be
thy medicine let medicine be thy food –
modeling simulation and leveraging the
power of high-performance computing
we’ve built a product development
platform that is applicable to the
development of IBD drugs but has the
potential to be applied to other
diseases such as type 1 diabetes
rheumatoid arthritis multiple sclerosis
type 2 diabetes we have embarked on a
journey of a faster path to cures we
have embarked on a journey not only to
address the symptoms of the disease and
the discomfort caused by inflammatory
bowel disease but also to address the
inefficiency of the drug development
process by leveraging the power of
modeling and simulation and were honored
to be able to tell us to Walker his
family and his friends as well as the 4
million other people afflicted by IBD
that hope is on the way thank you very
much [Applause]